TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
OBS! Utsatt för bedrägeri/ Neuroangiognosis NK AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
206
|
205
|
234 |
| Financial expenses |
0
|
0
|
8 |
| Earnings before taxes |
131
|
139
|
148 |
| EBITDA |
114
|
111
|
154 |
| Total assets |
1,712
|
1,641
|
1,470 |
| Current assets |
1,712
|
1,641
|
1,470 |
| Current liabilities |
332
|
282
|
204 |
| Equity capital |
1,308
|
1,276
|
1,188 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
76.4%
|
77.8%
|
80.8% |
| Turnover per employee |
206
|
205
|
234 |
| Profit as a percentage of turnover |
63.6%
|
67.8%
|
63.2% |
| Return on assets (ROA) |
7.7%
|
8.5%
|
10.6% |
| Current ratio |
515.7%
|
581.9%
|
720.6% |
| Return on equity (ROE) |
10.0%
|
10.9%
|
12.5% |
| Change turnover |
8
|
-30
|
-91 |
| Change turnover % |
4%
|
-13%
|
-28% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.